NOVELLI, Francesco
NOVELLI, Francesco
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
A 'stealth effect': adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions.
1999-01-01 GIOVARELLI M ;MUSIANI P ;GAROTTA G ;EBNER R ;DI CARLO E ;KIM Y ;CAPPELLO P ;RIGAMONTI L ;BERNABEI P ;NOVELLI F ;MODESTI A ;COLETTI A ;FERRIE AK ;LOLLINI PL ;RUBEN S ;SALCEDO T ;FORNI G
A bioluminescent mouse model of proliferation to highlight early stages of pancreatic cancer: A suitable tool for preclinical studies
2015-01-01 De Latouliere, L.A; Manni, I; Iacobini, C; Pugliese, G; Grazi, GL; Perri, P; Cappello, P; Novelli, F; Menini, S; Piaggio, G.
A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency.
2003-01-01 COURTOIS G; SMAHI A; REICHENBACH J; DOFFINGER R; CANCRINI C; BONNET M; PUEL A; BESSIA C; NOVELLI F; YAMAOKA S; FEINBERG J; DUPUIS-GIROD S; BODEMER C; LIVADIOTTI S; ROSSI P; FISCHER A; ISRAEL A; MUNNICH A; LE DEIST F; CASANOVA JL
A method and a kit for the in vitro diagnosis of pancreatic ductal adenocarcinoma or for determining the predisposition to pancreatic ductal adenocarcinoma
2012-01-01 F. Novelli; M. Capello; P. Cappello
A Mouse To Human Autoantibody Signature in Pancreatic Ductal Adenocarcinoma
2010-01-01 Capello Michela; Cappello Paola; Linty Federica; Scarpa Aldo; Pederzoli Paolo; Nisticò Paola; Milella Michele; Novelli Francesco
A neuroligin-2-YAP axis regulates progression of pancreatic intraepithelial neoplasia
2024-01-01 Middonti E.; Astanina E.; Vallariello E.; Hoza R.M.; Metovic J.; Spadi R.; Cristiano C.; Papotti M.; Allavena P.; Novelli F.; Parab S.; Cappello P.; Scarpa A.; Lawlor R.; Di Maio M.; Arese M.; Bussolino F.
A new T helper subset producing Interleukin 22 increases in multiplesclerosis patients.
2011-01-01 Simona Rolla; Valentina Bardina; Marinella Clerico; Paola Bonaventura; Pietro Quaglino; Giulia Contessa; Luca Durelli; Francesco Novelli
A selective defect of IFN-gamma- but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1.
1999-01-01 BOVOLENTA C; LORINI AL; MANTELLI B; CAMORALI L; F. NOVELLI; BISWAS P; POLI
A self antigen reopens the games in pancreatic cancer.
2013-01-01 Cappello P; Novelli F
Abstract 4984: Chemotherapy induces a coordinate autoantibody and T-cell response against tumor-associated antigens in pancreatic cancer patients
2016-01-01 Novelli, Francesco; Mandili, Giorgia; Mazza, Emanuela; Bulfamante, Sonia Bulfamante; Giordano, Daniele; Follia, Laura; Cappello, Paola
Abstract B49: Alpha-enolase knockdown reprograms metabolism and points out targetable pathways to counteract PDA growth
2015-01-01 Capello, Michela; Ferri-Borgogno, Sammy; Principe, Moitza; Chattaragada, Michelle Samuel; Riganti, Chiara; Zhou, Weidong; Follia, Laura; Liotta, Lance A.; Petricoin, Emanuel F.; Cappello, Paola; Novelli, Francesco
Adenosine A2a receptor stimulation blocks development of nonalcoholic steatohepatitis in mice by multilevel inhibition of signals that cause immunolipotoxicity
2017-01-01 Alchera, E;Rolla, S; Imarisio, C; Bardina, V; Valente, G; Novelli, F; Carini, R
Adriamycin-induced proteinuria in nude mice: an immune-system-mediated toxic effect.
1996-01-01 A. AMORE; G. MAZZUCCO; F. CAVALLO; G. FORNI; B. GIANOGLIO; M. MOTTA; L. PERUZZI; F. NOVELLI; M. G. PORCELLINI; G. CESANO; R. COPPO.
Alemtuzumab Long Term Immunological Study: The Immunosuppressive Effect Does Not Last More Than 48 Months
2016-01-01 Durelli, L; De Mercanti, S; Rolla, S; Cucci, A; Bardina, V; Cocco, E; Vladic, A; Soldo-Butkovic, S; Habek, M; Adamec, I; Annovazzi, P; Horakova, D; Novelli, F; Clerico, M
Alemtuzumab long-lasting immunological effects: a 48 months follow-up observation
2016-01-01 Durelli, L; De Mercanti, SF; Cucci, A; Taverna, D; Rolla, S; Bardina, V; Cocco, E; Vladic, A; Soldo-Butkovic, S; Habek, M; Adamec, I; Horakova, D; Annovazzi, P; Novelli, F; Clerico, M
Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months
2016-01-01 De Mercanti, Stefania; Rolla, Simona; Cucci, Angele; Bardina, Valentina; Cocco, Eleonora; Vladic, Anton; Soldo-Butkovic, Silva; Habek, Mario; Adamec, Ivan; Horakova, Dana; Annovazzi, Pietro; Novelli, Francesco; Durelli, Luca; Clerico, Marinella
Alemtuzumab treatment in MS how do the Treg cell function and suppressor cytokine mRNA (IL-10, TGF-beta, IL_27) levels change? 24-month immunological report during 323 and 324 genzyme trials
2012-01-01 De Mercanti, S.; Cucci, A.; Viglietti,E.; Giai Via,A.; Taverna, D.; Cimino,D.;Rolla, S.; Bardina,V.; Novelli, F.; Vargas,J.; Gibbin,M.; Piazza,F.; Vladic,A.; Brina.V.; Habek,M.; Cocco,E.; Annavazzi,P.; Horakova,D.; Clerico, M.; Durelli, L.
Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis
2017-01-01 Principe, Moitza; Borgoni, Simone; Cascione, Mariafrancesca; Chattaragada, Michelle Samuel; Ferri-Borgogno, Sammy; Capello, Michela; Bulfamante, Sara; Chapelle, Jennifer; Di Modugno, Francesca; Defilippi, Paola; Nisticò, Paola; Cappello, Paola; Riganti, Chiara; Leporatti, Stefano; Novelli, Francesco
Alpha-Enolase (ENO1), a potential target in novel immunotherapies
2017-01-01 Cappello Paola; Principe Moitza; Bulfamante Sara; Novelli Francesco
Alpha-enolase elicits specific adenocarcinoma pancreatic-T cell responses in healthy donors and tumor patients
2007-01-01 Novelli F; Tomaino B; Ciccarelli M; Capello M; Giovarelli M; Novarino A; Cappello P.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A 'stealth effect': adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions. | 1999 | GIOVARELLI M ;MUSIANI P ;GAROTTA G ;EBNER R ;DI CARLO E ;KIM Y ;CAPPELLO P ;RIGAMONTI L ;BERNABEI P ;NOVELLI F ;MODESTI A ;COLETTI A ;FERRIE AK ;LOLLINI PL ;RUBEN S ;SALCEDO T ;FORNI G | |
| A bioluminescent mouse model of proliferation to highlight early stages of pancreatic cancer: A suitable tool for preclinical studies | 2015 | De Latouliere, L.A; Manni, I; Iacobini, C; Pugliese, G; Grazi, GL; Perri, P; Cappello, P; Novelli, F; Menini, S; Piaggio, G. | |
| A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. | 2003 | COURTOIS G; SMAHI A; REICHENBACH J; DOFFINGER R; CANCRINI C; BONNET M; PUEL A; BESSIA C; NOVELLI F; YAMAOKA S; FEINBERG J; DUPUIS-GIROD S; BODEMER C; LIVADIOTTI S; ROSSI P; FISCHER A; ISRAEL A; MUNNICH A; LE DEIST F; CASANOVA JL | |
| A method and a kit for the in vitro diagnosis of pancreatic ductal adenocarcinoma or for determining the predisposition to pancreatic ductal adenocarcinoma | 2012 | F. Novelli; M. Capello; P. Cappello | |
| A Mouse To Human Autoantibody Signature in Pancreatic Ductal Adenocarcinoma | 2010 | Capello Michela; Cappello Paola; Linty Federica; Scarpa Aldo; Pederzoli Paolo; Nisticò Paola; Milella Michele; Novelli Francesco | |
| A neuroligin-2-YAP axis regulates progression of pancreatic intraepithelial neoplasia | 2024 | Middonti E.; Astanina E.; Vallariello E.; Hoza R.M.; Metovic J.; Spadi R.; Cristiano C.; Papotti M.; Allavena P.; Novelli F.; Parab S.; Cappello P.; Scarpa A.; Lawlor R.; Di Maio M.; Arese M.; Bussolino F. | |
| A new T helper subset producing Interleukin 22 increases in multiplesclerosis patients. | 2011 | Simona Rolla; Valentina Bardina; Marinella Clerico; Paola Bonaventura; Pietro Quaglino; Giulia Contessa; Luca Durelli; Francesco Novelli | |
| A selective defect of IFN-gamma- but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1. | 1999 | BOVOLENTA C; LORINI AL; MANTELLI B; CAMORALI L; F. NOVELLI; BISWAS P; POLI | |
| A self antigen reopens the games in pancreatic cancer. | 2013 | Cappello P; Novelli F | |
| Abstract 4984: Chemotherapy induces a coordinate autoantibody and T-cell response against tumor-associated antigens in pancreatic cancer patients | 2016 | Novelli, Francesco; Mandili, Giorgia; Mazza, Emanuela; Bulfamante, Sonia Bulfamante; Giordano, Daniele; Follia, Laura; Cappello, Paola | |
| Abstract B49: Alpha-enolase knockdown reprograms metabolism and points out targetable pathways to counteract PDA growth | 2015 | Capello, Michela; Ferri-Borgogno, Sammy; Principe, Moitza; Chattaragada, Michelle Samuel; Riganti, Chiara; Zhou, Weidong; Follia, Laura; Liotta, Lance A.; Petricoin, Emanuel F.; Cappello, Paola; Novelli, Francesco | |
| Adenosine A2a receptor stimulation blocks development of nonalcoholic steatohepatitis in mice by multilevel inhibition of signals that cause immunolipotoxicity | 2017 | Alchera, E;Rolla, S; Imarisio, C; Bardina, V; Valente, G; Novelli, F; Carini, R | |
| Adriamycin-induced proteinuria in nude mice: an immune-system-mediated toxic effect. | 1996 | A. AMORE; G. MAZZUCCO; F. CAVALLO; G. FORNI; B. GIANOGLIO; M. MOTTA; L. PERUZZI; F. NOVELLI; M. G. PORCELLINI; G. CESANO; R. COPPO. | |
| Alemtuzumab Long Term Immunological Study: The Immunosuppressive Effect Does Not Last More Than 48 Months | 2016 | Durelli, L; De Mercanti, S; Rolla, S; Cucci, A; Bardina, V; Cocco, E; Vladic, A; Soldo-Butkovic, S; Habek, M; Adamec, I; Annovazzi, P; Horakova, D; Novelli, F; Clerico, M | |
| Alemtuzumab long-lasting immunological effects: a 48 months follow-up observation | 2016 | Durelli, L; De Mercanti, SF; Cucci, A; Taverna, D; Rolla, S; Bardina, V; Cocco, E; Vladic, A; Soldo-Butkovic, S; Habek, M; Adamec, I; Horakova, D; Annovazzi, P; Novelli, F; Clerico, M | |
| Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months | 2016 | De Mercanti, Stefania; Rolla, Simona; Cucci, Angele; Bardina, Valentina; Cocco, Eleonora; Vladic, Anton; Soldo-Butkovic, Silva; Habek, Mario; Adamec, Ivan; Horakova, Dana; Annovazzi, Pietro; Novelli, Francesco; Durelli, Luca; Clerico, Marinella | |
| Alemtuzumab treatment in MS how do the Treg cell function and suppressor cytokine mRNA (IL-10, TGF-beta, IL_27) levels change? 24-month immunological report during 323 and 324 genzyme trials | 2012 | De Mercanti, S.; Cucci, A.; Viglietti,E.; Giai Via,A.; Taverna, D.; Cimino,D.;Rolla, S.; Bardina,V.; Novelli, F.; Vargas,J.; Gibbin,M.; Piazza,F.; Vladic,A.; Brina.V.; Habek,M.; Cocco,E.; Annavazzi,P.; Horakova,D.; Clerico, M.; Durelli, L. | |
| Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis | 2017 | Principe, Moitza; Borgoni, Simone; Cascione, Mariafrancesca; Chattaragada, Michelle Samuel; Ferri-Borgogno, Sammy; Capello, Michela; Bulfamante, Sara; Chapelle, Jennifer; Di Modugno, Francesca; Defilippi, Paola; Nisticò, Paola; Cappello, Paola; Riganti, Chiara; Leporatti, Stefano; Novelli, Francesco | |
| Alpha-Enolase (ENO1), a potential target in novel immunotherapies | 2017 | Cappello Paola; Principe Moitza; Bulfamante Sara; Novelli Francesco | |
| Alpha-enolase elicits specific adenocarcinoma pancreatic-T cell responses in healthy donors and tumor patients | 2007 | Novelli F; Tomaino B; Ciccarelli M; Capello M; Giovarelli M; Novarino A; Cappello P. |